Table 1.
Summary of Demographic Characteristics in the Total Vaccinated Cohorts
| Characteristic | RSV F-020 | RSV F-024 | ||||
|---|---|---|---|---|---|---|
| 30RSV-PreF (n = 126) | 60RSV-PreF (n = 124) | 60RSV-PreF-Al (n = 125) | Tdap (n = 125) | 60RSV-PreF (n = 49) | Tdap (n = 51) | |
| Age at vaccination, y | ||||||
| Mean ± SD | 29.2 ± 7.5 | 29.5 ± 8.2 | 29.1 ± 7.4 | 29.2 ± 7.9 | 25.8 ± 5.9 | 25.6 ± 6.1 |
| Range | 19–45 | 18–45 | 18–45 | 18–45 | 19–45 | 19–43 |
| Geographic ancestry, no. (%) | ||||||
| African/African American | 5 (4.0) | 7 (5.6) | 9 (7.2) | 9 (7.2) | 0 (0.0) | 0 (0.0) |
| Asiana | 3 (2.4) | 1 (0.8) | 12 (9.6) | 4 (3.2) | 0 (0.0) | 1 (2.0) |
| White/European | 112 (88.9) | 114 (91.9) | 97 (77.6) | 108 (86.4) | 49 (100) | 50 (98.0) |
| Other | 6 (4.8) | 2 (1.6) | 7 (5.6) | 4 (3.2) | 0 (0.0) | 0 (0.0) |
The 30RSV-PreF group received nonadjuvanted respiratory syncytial virus (RSV) vaccine containing 30 µg of RSV–prefusion F protein (PreF), the 60RSV-PreF groups received nonadjuvanted RSV vaccine containing 60 µg of RSV PreF, the 60RSV-PreF-Al group received aluminum-adjuvanted RSV vaccine containing 60 µg of RSV PreF, and the Tdap groups received an adult formulation of combined tetanus toxoid-diphtheria toxoid-acellular pertussis vaccine.
aParticipants of Central/South Asian, East Asian, Japanese, or Southeast Asian heritage.